Is Regeneron Pharmaceuticals, Inc. (REGN) a Buy, Sell, or Hold?
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$656.12 USD
-$6.97 (-1.05%)
- Volume
- 477.99K
- Average Volume
- 1.01M
- Market Capitalization
- $67.59B
- P/E Ratio
- 15.43
- Dividend Yield
- 0.55%
- Price Target
- $839.50
- Year High
- $821.11
- Year Low
- $541.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.08
- Current Ratio
- $3.57
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.71%
Investors Holding
100
change: -1353 | last: 1453
Increased Positions
41
change: -670 | last: 711
Reduced Positions
33
change: -430 | last: 463
New Positions
9
change: -128 | last: 137
Sold Positions
1307
change: 1175 | last: 132
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -108.5252 | last: 1.0853
Total Invested
438.59M
REGN Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $771.87 | 104.6M | $80.74B | $3.12B | $2.71B | $80.33B |
| 2024-12-31 | $712.33 | 107.9M | $76.86B | $2.49B | $2.7B | $77.08B |
| 2023-12-31 | $878.29 | 106.7M | $93.71B | $2.73B | $2.7B | $93.69B |
| 2022-12-31 | $721.49 | 107.1M | $77.27B | $3.11B | $2.7B | $76.87B |
| 2021-12-31 | $631.52 | 105.7M | $66.75B | $2.89B | $2.7B | $66.57B |
| 2020-12-31 | $483.11 | 107.6M | $51.98B | $2.19B | $2.7B | $52.48B |
| 2019-12-31 | $375.48 | 109.2M | $41B | $1.62B | $713.9M | $40.1B |
| 2018-12-31 | $373.50 | 114.8M | $42.88B | $1.47B | $708.5M | $42.12B |
| 2017-12-31 | $375.96 | 115.9M | $43.57B | $812.73M | $703.45M | $43.46B |
| 2016-12-31 | $367.09 | 116.25M | $42.67B | $535.2M | $481.13M | $42.62B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $772.64 | 104M | $80.35B | $2.96B | $2.71B | $80.1B |
| 2025-12-31 | $771.87 | 102.9M | $79.43B | $3.12B | $2.71B | $79.01B |
| 2025-09-30 | $562.27 | 103.62M | $58.26B | $2.51B | $2.71B | $58.46B |
| 2025-06-30 | $525.00 | 105.1M | $55.18B | $2B | $2.71B | $55.89B |
| 2025-03-31 | $634.23 | 106.7M | $67.67B | $3.09B | $2.7B | $67.29B |
| 2024-12-31 | $712.33 | 107.9M | $76.86B | $2.49B | $2.7B | $77.08B |
| 2024-09-30 | $1051.24 | 108.1M | $113.64B | $2.01B | $2.7B | $114.33B |
| 2024-06-30 | $1057.02 | 108.1M | $114.26B | $1.92B | $2.7B | $115.05B |
| 2024-03-31 | $969.31 | 107.8M | $104.49B | $2.6B | $2.7B | $104.59B |
| 2023-12-31 | $878.29 | 106.6M | $93.63B | $2.73B | $2.7B | $93.6B |
| 2023-09-30 | $822.96 | 106.3M | $87.48B | $2.15B | $2.7B | $88.03B |
| 2023-06-30 | $718.54 | 107M | $76.88B | $1.94B | $2.7B | $77.65B |